Ten healthy volunteers received 400 mg of enoxacin and another ten healthy volunteers received 200 mg of norfloxacin orally twice a day for 7 days. Fecal specimens were collected before, during, and after drug administration to study the impact of enoxacin and norfloxacin on the normal colonic microflora. On day 7, the mean concentrations of enoxacin abd norfloxacin were 350 and 950 mg/kg of feces, respectively. Enoxacin and norfloxacin affected the colonic microfloral in similar ways. The number of strains of the family Enterobacteriaceae was markedly suppressed during drug administration, whereas the gram-positive and anaerobic microfioras were not significantly altered. Two weeks after withdrawal of the drugs, the colonic microflora had returned to normal.Enoxacin and norfloxacin are members of the 4-quinolone group of antimicrobial agents, whose in vitro activity is primarily directed against a broad spectrum of aerobic gram-negative bacteria, including members of the family Enterobacteriaceae and Pseudomonas aeruginosa (3,6,12). Enoxacin and norfloxacin have moderate activities against gram-positive microorganisms, such as staphylococci and stteptococci; anaerobic bacteria are generally resistant. The 4-quinolones may be used in prophylactic and suppressive long-term treatment, i.e., in urological surgery or complicated urinary tract infections, and for selective decontamination of the gut in immunocompromised patients (10,13,15). Treatment with antimicrobial agents can induce undesited changes in the gastrointestinal microflora (11), and it is therefore of clinical interest to investigate the effect of new agents on such microflora. In this article, the effects on the colonic microflora of enoxacin and norfloxacin in human volunteers are described.Twenty healthy volunteers participated in the study. None of them had received any antimicrobial agent during the 3 weeks before the investigation. The study was approved by the Local Ethics Committee of Karolinska Institute, Stockholm, Sweden. No other medication except oral contraceptives was allowed during the investigation period.In the enoxacin group, five females and five males (median age, 33 years; range, 37 to 64 years) received 400 mg of enoxacin (supplied by Warner-Lambert Co., Morris Plains, N.J.) perorally twice a day for 7 days. The tablets were taken with 100 ml of water just before meals. Stool specimens were collected in sterile plastic containers before the administration period (day 0) and on days 2, 4, 7, 9, 11, 16, and 21. In the norfloxacin group, five femnales and five males (median age, 30 years; range, 24 to 37 years) received 200 mg of norfloxacin (supplied by Astra Lakemedel AB, Sodertalje, Sweden) perorally twice a day for 7 days. The tablets were administered before meals with 100 ml of water. Stool specimens were collected in sterile plastic containers on days 0, 3, 5, 7, 14, and 21. All fecal specimens were stored at -70°C until assayed.The fecal concentrations of enoxacin and norfloxacin were assayed by the agar well diffusion meth...